Is Kenvi Jewels overvalued or undervalued?

Oct 03 2025 08:10 AM IST
share
Share Via
As of October 1, 2025, Kenvi Jewels is considered very attractive and undervalued with a PE ratio of 34.38, significantly lower than its peers Titan Company and Kalyan Jewellers, despite a recent stock decline of 44.99%, indicating potential for future recovery and growth.
As of 1 October 2025, the valuation grade for Kenvi Jewels has moved from attractive to very attractive. The company is currently considered undervalued. Key ratios include a PE ratio of 34.38, an EV to EBITDA of 15.99, and a ROCE of 13.30%.
In comparison to peers, Kenvi Jewels has a significantly lower PE ratio than Titan Company, which stands at 81.35, and Kalyan Jewellers, which is at 59.95, indicating that Kenvi Jewels may be undervalued relative to its competitors. Despite recent stock performance showing a decline of 44.99% over the past year compared to a slight drop in the Sensex, the company's strong valuation metrics suggest it has potential for recovery and growth in the future.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
Saboo Sodium Chloro Ltd is Rated Sell
51 minutes ago
share
Share Via
Jenburkt Pharmaceuticals Ltd. is Rated Sell
51 minutes ago
share
Share Via
iStreet Network Ltd is Rated Sell
51 minutes ago
share
Share Via
Emmbi Industries Ltd is Rated Sell
51 minutes ago
share
Share Via
Cohance Lifesciences Ltd is Rated Sell
51 minutes ago
share
Share Via
Vivo Bio Tech Ltd. is Rated Strong Sell
51 minutes ago
share
Share Via